Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility
San Diego, California–(Newsfile Corp. – April 5, 2021) – Tryp Therapeutics (CNSX:TRYP.CN) (OTCQB:TRYPF) (” Tryp ” or the ” Company “) a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today it has initiated quoting activity on the OTCQB® Venture Market (the ” OTCQB “) and is eligible for settlement and transfer of its common […]
MindMed Announces the Publication of New Data on Personalized MDMA Dosing
BASEL, Switzerland, April 5, 2021 /PRNewswire/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading clinical-stage psychedelic medicine biotech company, announced the publication of the first study on MDMA dosing optimization using personalized medicine. The study took place at the University Hospital Basel Liechti Lab, in Basel, Switzerland. This study provides the first scientific data for predicting responses to […]
